Robert Wieder

Publications

• Prescription Coverage in Indigent Patients Affects the Use of Long-acting Opioids in the Management of Cancer Pain
  Pain Medicine (Malden, Mass.). Jan, 2014  |   Pubmed ID: 24106748
• Establishing a Minority-based Community Clinical Oncology Program: the University of Medicine and Dentistry of New Jersey, New Jersey Medical School-university Hospital Cancer Center Experience
  Journal of Oncology Practice / American Society of Clinical Oncology. Mar, 2013  |   Pubmed ID: 23814524
• Collagen I Provides a Survival Advantage to MD-1483 Head and Neck Squamous Cell Carcinoma Cells Through Phosphoinositol 3-kinase Signaling
  Anticancer Research. Feb, 2013  |   Pubmed ID: 23393327
• Determination of Single Cell Surface Protein Expression Using a Tagless Microfluidic Method
  Lab on a Chip. May, 2012  |   Pubmed ID: 22415775
• A Pilot Phase II Trial of All-trans Retinoic Acid (Vesanoid) and Paclitaxel (Taxol) in Patients with Recurrent or Metastatic Breast Cancer
  Investigational New Drugs. Dec, 2011  |   Pubmed ID: 20596747
• Dual FGF-2 and Intergrin Alpha5beta1 Signaling Mediate GRAF-induced RhoA Inactivation in a Model of Breast Cancer Dormancy
  Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. Dec, 2009  |   Pubmed ID: 19308677
• CCAAT Enhancer-binding Protein Alpha is a Molecular Target of 1,25-dihydroxyvitamin D3 in MCF-7 Breast Cancer Cells
  The Journal of Biological Chemistry. Jan, 2009  |   Pubmed ID: 19054766
• Influence of Prescription Benefits on Reported Pain in Cancer Patients
  Pain Medicine (Malden, Mass.). Nov, 2008  |   Pubmed ID: 18346057
• Coordinate Loss of Fibroblast Growth Factor 2 and Laminin 5 Expression During Neoplastic Progression of Mammary Duct Epithelium
  Human Pathology. Jan, 2007  |   Pubmed ID: 16996573
• Microfluidic Techniques for Single-cell Protein Expression Analysis
  Clinical Chemistry. Jun, 2006  |   Pubmed ID: 16556686
• TUNEL Assay As a Measure of Chemotherapy-induced Apoptosis
  Methods in Molecular Medicine. 2005  |   Pubmed ID: 15911970
• Flavopiridol Blocks Integrin-mediated Survival in Dormant Breast Cancer Cells
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2005  |   Pubmed ID: 15756030
• Insurgent Micrometastases: Sleeper Cells and Harboring the Enemy
  Journal of Surgical Oncology. Mar, 2005  |   Pubmed ID: 15726617
• Expression of FGF-2 Alters Focal Adhesion Dynamics in Migration-restricted MDA-MB-231 Breast Cancer Cells
  Breast Cancer Research and Treatment. Nov, 2004  |   Pubmed ID: 15538042
• Integrin Alpha5beta1 Promotes Survival of Growth-arrested Breast Cancer Cells: an in Vitro Paradigm for Breast Cancer Dormancy in Bone Marrow
  Cancer Research. Jul, 2004  |   Pubmed ID: 15231661
• All-trans Retinoic Acid Potentiates Taxotere-induced Cell Death Mediated by Jun N-terminal Kinase in Breast Cancer Cells
  Oncogene. Jan, 2004  |   Pubmed ID: 14724571
• Pharmacokinetics and Safety of ILX23-7553, a Non-calcemic-vitamin D3 Analogue, in a Phase I Study of Patients with Advanced Malignancies
  Investigational New Drugs. Nov, 2003  |   Pubmed ID: 14586212
• Phase I/II Trial of Accutane As a Potentiator of Carboplatin and Paclitaxel in Squamous Cell Carcinomas
  American Journal of Clinical Oncology. Oct, 2002  |   Pubmed ID: 12393981